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There is a large interest in the radiobiological response 
to the exposure to Radon gas because of two reasons: In 
many areas, radon gas emanates from the soil containing 
uranium isotopes and its daughter nuclei .There, a chronic 
exposure to radon gas and its decay products is probably 
the main reason for tumor induction after smoking. [1] 
But radon is also used in the medical treatment of in-
flammatory diseases such as ankolysing spondilitis. Every 
year some ten thousand rheumatic patients undergo radon 
inhalations, total body exposure or bathing in radon con-
taining water. [2] 
In the past, the effects of the chronic exposure have 
been mainly studied in epidemiologic projects in the ra-
don exposed areas while separately the anti-inflammatory 
reaction was mainly studied in patients after radon expo-
sure. [3] In both cases the dosimetry, i.e. the amount and 
the time-distribution of incorporated radon-progenies over 
the body, is not very well known. 
In future experiments we want to study the radiobio-
logical effects of radon exposure in vitro and in vivo un-
der precisely controlled conditions concerning the radon 
activity, the exposure timing, the temperature and other 
parameters that might influence the radon uptake and the 
metabolism of the biological objects. For this purpose a 
radon exposure chamber has been constructed in the last 
year and is presently under initial operation in order to 
study both effects, the anti-inflammatory behaviour and 
the mutagenic alterations in cell culture and in mice. 
 
Requirements for measurement setup 
In the radon exposure chamber the same conditions like 
in radon galleries and in the vapour bath both at Bad 
Gastein should be simulated (temperature 37°C, relative 
humidity 70-100%, activity-concentration 44-
440kBq/m³). These variables must be monitored and 
regulated during the experiments. For experiments with 
cells the CO2-concentration has to be controlled. 
As we want to do experiments with cells and also with 
small animals, there must be space for a cage inside the 
chamber and the whole system must meet the require-
ments of the Protection of Animals Act. 
Results 
The chamber in its present design is a barrel made of 
stainless steel with plane surfaces and has a content of 
50 l. There is a hermetic seal between the cover plate and 
the body. 
For a schematic drawing of the whole system see fig-
ure 1. The chamber is immersed in a water bath. So the 
temperature can be regulated. The gas is coming from a 
Radium-226 source which emanates Radon-222. The ra-
don is guided into the chamber or - when the radon is not 
needed for experiments - directly into an absorption filter 
of activated carbon where it is absorbed completely. 
For the air moistening system controlled volumes of 
gas and fluid are mixed and evaporated. The steam is then 
routed to the chamber. With this system contaminations of 
the chamber can be avoided. 
 
 
Figure 1: schematic drawing. 
After the experiment the system is flushed with normal 
air to get rid of the radon inside the chamber and one can 
open the system and take out the samples without any risk 
of contamination 
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